Gene therapy company enGene goes public via SPAC

A Boston biotech has begun trading publicly as of Wednesday, only the second Massachusetts company to hit Wall Street using a SPAC merger.

Previous Atlanta's big office landlords: 'Return to office' trends encouraging
Next Pulte Homes' new Towns on the Parkway development in Dublin to include 154 townhome units